Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.

MLA

Slade, M. J., et al. “Comparison of Bone Marrow, Disseminated Tumour Cells and Blood-Circulating Tumour Cells in Breast Cancer Patients after Primary Treatment.” British Journal of Cancer, vol. 100, no. 1, Jan. 2009, pp. 160–66. EBSCOhost, https://doi.org/10.1038/sj.bjc.6604773.

APA

Slade, M. J., Payne, R., Riethdorf, S., Ward, B., Zaidi, S. A. A., Stebbing, J., Palmieri, C., Sinnett, H. D., Kulinskaya, E., Pitfield, T., McCormack, R. T., Pantel, K., & Coombes, R. C. (2009). Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. British Journal of Cancer, 100(1), 160–166. https://doi.org/10.1038/sj.bjc.6604773

Chicago

Slade, M. J., R. Payne, S. Riethdorf, B. Ward, S. A. A. Zaidi, J. Stebbing, C. Palmieri, et al. 2009. “Comparison of Bone Marrow, Disseminated Tumour Cells and Blood-Circulating Tumour Cells in Breast Cancer Patients after Primary Treatment.” British Journal of Cancer 100 (1): 160–66. doi:10.1038/sj.bjc.6604773.